Unknown

Dataset Information

0

Recent progress in radioactive seed implantation brachytherapy of non-small cell lung cancer: a narrative review.


ABSTRACT:

Background and objective

Brachytherapy, a new form of radiation therapy, has been used to treat lung cancer and consists of two main forms of treatment: endobronchial brachytherapy and radioactive seed implantation brachytherapy (RSI-BT), the latter of which is used to treat non-small cell lung cancer (NSCLC). The use of RSI-BT in the treatment of NSCLC at our centre has yielded some positive results.

Methods

To more fully consider the context of this application, we conducted a search of PubMed from 2018 to March 5, 2023. The search included a combination of the MeSH terms: "brachytherapy" and "lung neoplasm".

Key content and findings

The majority of NSCLC patients who received RSI-BT achieved positive benefits. Most patients had a progression-free survival (PFS) of between 12 and 18 months. Additionally, radioactive particle stent implantation as a specific RSI-BT has shown therapeutic potential in the treatment of malignant airway obstruction. With the application of new technologies, RSI-BT will become more precise, efficient and inexpensive.

Conclusions

This review demonstrates that RSI-BT can be therapeutic in the treatment of both early and advanced NSCLC with manageable complications. There have also been reports on the combination of RSI-BT with other therapies, but more research is needed on the combination of RSI-BT with them.

SUBMITTER: Wang X 

PROVIDER: S-EPMC11009575 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recent progress in radioactive seed implantation brachytherapy of non-small cell lung cancer: a narrative review.

Wang Xinyu X   Tian Sen S   Shi Hui H   Qin Hao H   Zhang Wei W   Dong Yuchao Y   Bai Chong C  

Journal of thoracic disease 20240325 3


<h4>Background and objective</h4>Brachytherapy, a new form of radiation therapy, has been used to treat lung cancer and consists of two main forms of treatment: endobronchial brachytherapy and radioactive seed implantation brachytherapy (RSI-BT), the latter of which is used to treat non-small cell lung cancer (NSCLC). The use of RSI-BT in the treatment of NSCLC at our centre has yielded some positive results.<h4>Methods</h4>To more fully consider the context of this application, we conducted a s  ...[more]

Similar Datasets

| S-EPMC8107727 | biostudies-literature
| S-EPMC9994183 | biostudies-literature
| S-EPMC6886531 | biostudies-literature
| S-EPMC4497796 | biostudies-literature
| S-EPMC10728551 | biostudies-literature
| S-EPMC11320285 | biostudies-literature
| S-EPMC5972355 | biostudies-literature
| S-EPMC9442518 | biostudies-literature
| S-EPMC9673601 | biostudies-literature
| S-EPMC9840049 | biostudies-literature